A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects
NCT ID: NCT00449501
Last Updated: 2011-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
134 participants
INTERVENTIONAL
2007-03-31
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects
NCT00449527
An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma
NCT00419757
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
NCT02224157
Titratable Dosing in Moderate to Severe Asthmatics
NCT00651768
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
NCT02495168
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Budesonide/formoterol pMDI
Budesonide HFA pMDI
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild to moderate asthma requiring treatment with an inhaled corticosteroid
* Diagnosis of asthma for at least 6 months
Exclusion Criteria
* Subjects with severe asthma, as judged by investigator
* Any significant disease or disorder that may jeopardize a subject's safety
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tomas LG Andersson, MD
Role: STUDY_DIRECTOR
AstraZenenca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Muscle Shoals, Alabama, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Los Angeles, California, United States
Research Site
Palmdale, California, United States
Research Site
Rolling Hills Estates, California, United States
Research Site
Denver, Colorado, United States
Research Site
Wheat Ridge, Colorado, United States
Research Site
Stamford, Connecticut, United States
Research Site
Wilmington, Delaware, United States
Research Site
Miami, Florida, United States
Research Site
Avon, Indiana, United States
Research Site
Iowa City, Iowa, United States
Research Site
Shawnee Mission, Kansas, United States
Research Site
Mandeville, Louisiana, United States
Research Site
Wheaton, Maryland, United States
Research Site
Bay City, Michigan, United States
Research Site
Chesterfield, Missouri, United States
Research Site
Kansas City, Missouri, United States
Research Site
McCook, Nebraska, United States
Research Site
Scottsbluff, Nebraska, United States
Research Site
Brick, New Jersey, United States
Research Site
Princeton, New Jersey, United States
Research Site
North Syracuse, New York, United States
Research Site
Bismarck, North Dakota, United States
Research Site
Fargo, North Dakota, United States
Research Site
Akron, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Bend, Oregon, United States
Research Site
Lake Oswego, Oregon, United States
Research Site
Bensalem, Pennsylvania, United States
Research Site
Feasterville, Pennsylvania, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
East Providence, Rhode Island, United States
Research Site
Charleston, South Carolina, United States
Research Site
Gaffney, South Carolina, United States
Research Site
Greer, South Carolina, United States
Research Site
Rapid City, South Dakota, United States
Research Site
Watertown, South Dakota, United States
Research Site
Boerne, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
El Paso, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Waco, Texas, United States
Research Site
Provo, Utah, United States
Research Site
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Leidy NK, Gutierrez B, Lampl K, Uryniak T, O'Brien CD. Can patients with asthma feel inhaler therapy working right away? Two clinical trials testing the effect of timing of assessment on patient perception. J Asthma. 2009 Dec;46(10):1006-12. doi: 10.3109/02770900903301260.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D5896C00025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.